Protective effect of human heat shock protein 60 suggested by its association with decreased seropositivity to pathogens

Clinical and Vaccine Immunology

Volumn 14, Issue 2, 2007, Pages 204-207

  Steptoe, A ^a   Shamaei Tousi, A ^a   Gylfe, A ^b   Bailey, L ^b   Bergstrom S ^b   Coates, A R ^c   Henderson, B ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UMEÅ UNIVERSITY   (Sweden)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 60; VIRUS ANTIBODY;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BACTERIAL INFECTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHLAMYDIA; CONTROLLED STUDY; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; FEMALE; HERPES SIMPLEX VIRUS; HUMAN; IMMUNOFLUORESCENCE; MALE; MICROORGANISM DETECTION; PRIORITY JOURNAL; SEROLOGY; VIRUS INFECTION;

AGED; ANTIBODIES; CHAPERONIN 60; CHLAMYDIA; CYTOMEGALOVIRUS; FEMALE; HUMANS; MALE; MIDDLE AGED; SIMPLEXVIRUS;

EID: 33947138677     PISSN: 15566811     EISSN: None     Source Type: Journal    
DOI: 10.1128/CVI.00179-06     Document Type: Article

References (29)

1. Bason, C., R. Corrocher, C. Lunardi, P. Puccetti, O. Olivieri, D. Girelli, R. Navone, R. Beri, E. Millo, A. Margonato, N. Martinelli, and A. Puccetti. 2003. Interaction of antibodies against cytomegalovirus with heat-shock protein 60 in pathogenesis of atherosclerosis. Lancet 362:1971-1977.
2. Burian, K., Z. Kis, D. Virok, V. Endresz, Z. Prohaszka, J. Duba, K. Berencsi, K. Boda, L. Horvath, L. Romics, G. Fust, and E. Gonczol. 2001. Independent and joint effects of antibodies to human heat-shock protein 60 and Chlamydia pneumoniae infection in the development of coronary atherosclerosis. Circulation 103:1503-1508.
3. Cohen, I. R. 2002. Peptide therapy for type I diabetes: the immunological homunculus and the rationale for vaccination. Diabetologia 45:1468-1474.
4. Cohen-Sfady, M., G. Nussbaum, M. Pevsner-Fischer, F. Mor, P. Carmi, A. Zanin-Zhorov, O. Lider, and I. R. Cohen. 2005. Heat shock protein 60 activates B cells via the TLR4-MyD88 pathway. J. Immunol. 175:3594-3602.
5. Erkkila, L., K. Laitinen, K. Haasio, T. Tiirola, M. Jauhiainen, H. A. Lehr, K. alto-Setala, P. Saikku, and M. Leinonen. 2004. Heat shock protein 60 autoimmunity and early lipid lesions in cholesterol-fed C57BL/6JBom mice during Chlamydia pneumoniae infection. Atherosclerosis 177:321-328.
6. Gaston, J. S., P. F. Life, L. C. Balley, and P. A. Bacon. 1989. In vitro responses to a 65-kilodalton mycobacterial protein by synovial T cells from inflammatory arthritis patients. J. Immunol. 143:2494-2500.
7. Halcox, J. P., J. Deanfield, A. Shamaei-Tousi, B. Henderson, A. Steptoe, A. R. Coates, A. Singhal, and A. Lucas. 2005. Circulating human heat shock protein 60 in the blood of healthy teenagers: a novel determinant of endothelial dysfunction and early vascular injury? Arterioscler. Thromb. Vasc. Biol. 25:e141-e142.
8. Hartl, F. U., and M. Hayer-Hartl. 2002. Molecular chaperones in the cytosol: from nascent chain to folded protein. Science 295:1852-1858.
9. Hemmingsen, S. M., C. Woolford, S. M. van der Vies, K. Tilly, D. T. Dennis, C. P. Georgopoulos, R. W. Hendrix, and R. J. Ellis. 1988. Homologous plant and bacterial proteins chaperone oligomeric protein assembly. Nature 333: 330-334.
10. Henderson, B., and A. G. Pockley (ed.). 2005. Molecular chaperones and cell signalling. Cambridge University Press, Cambridge, United Kingdom.
11. Ismail, A., H. Khosravi, and H. Olson. 1999. The role of infection in atherosclerosis and coronary artery disease: a new therapeutic target. Heart Dis. 1:233-240.
12. Juto, P., and B. Settergren. 1988. Specific serum IgA, IgG and IgM antibody determination by a modified indirect ELISA-technique in primary and recurrent herpes simplex virus infection. J. Virol. Methods 20:45-55.
13. Kaijser, B. 1975. Immunological studies of an antigen common to many gram-negative bacteria with special reference to E. coli. Characterization and biological significance. Int. Arch. Allergy Appl. Immunol. 48:72-81.
14. Karunakaran, K. P., Y. Noguchi, T. D. Read, A. Cherkasov, J. Kwee, C. Shen, C. C. Nelson, and R. C. Brunham. 2003. Molecular analysis of the multiple GroEL proteins of Chlamydiae. J. Bacteriol. 185:1958- 1966.
15. Lewthwaite, J., N. Owen, A. Coates, B. Henderson, and A. Steptoe. 2002. Circulating human heat shock protein 60 in the plasma of British civil servants: relationship to physiological and psychosocial stress. Circulation 106:196-201.
16. Maguire, M., A. R. Coates, and B. Henderson. 2002. Chaperonin 60 unfolds its secrets of cellular communication. Cell Stress Chaperones 7:317-329.
17. Maguire, M., S. Poole, A. R. Coates, P. Tormay, C. Wheeler-Jones, and B. Henderson. 2005. Comparative cell signalling activity of ultrapure recombinant chaperonin 60 proteins from prokaryotes and eukaryotes. Immunology 115:231-238.
18. Marmot, M. G. 2003. Understanding social inequalities in health. Perspect. Biol. Med. 46:S9-S23.
19. Marmot, M. G., G. D. Smith, S. Stansfeld, C. Patel, F. North, J. Head, I. White, E. Brunner, and A. Feeney. 1991. Health inequalities among British civil servants: the Whitehall II study. Lancet 337:1387-1393.
20. Minowada, G., and W. J. Welch. 1995. Clinical implications of the stress response. J. Clin. Investig. 95:3-12.
21. Pockley, A. G., J. Bulmer, B. M. Hanks, and B. H. Wright. 1999. Identification of human heat shock protein 60 (Hsp60) and anti-Hsp60 antibodies in the peripheral circulation of normal individuals. Cell Stress Chaperones 4:29-35.
22. Pockley, A. G., R. Wu, C. Lemne, R. Kiessling, U. de Faire, and J. Frostegard. 2000. Circulating heat shock protein 60 is associated with early cardiovascular disease. Hypertension 36:303-307.
23. Shamaei-Tousi, A., J. W. Stephens, R. Bin, J. A. Cooper, A. Steptoe, A. R. Coates, B. Henderson, and S. E. Humphries. 2006. Association between plasma levels of heat shock protein 60 and cardiovascular disease in patients with diabetes mellitus. Eur. Heart J. 27:1565-1570.
24. Stansfeld, S. A., R. Fuhrer, M. J. Shipley, and M. G. Marmot. 2002. Psychological distress as a risk factor for coronary heart disease in the Whitehall II Study. Int. J. Epidemiol. 31:248-255.
25. van Eden, W., R. van der Zee, and B. Prakken. 2005. Heat-shock proteins induce T-cell regulation of chronic inflammation. Nat. Rev. Immunol. 5:318-330.
26. Wick, G., M. Knoflach, and Q. Xu. 2004. Autoimmune and inflammatory mechanisms in atherosclerosis. Annu. Rev. Immunol. 22:361-403.
27. Xu, Q., G. Schett, H. Perschinka, M. Mayr, G. Egger, F. Oberhollenzer, J. Willeit, S. Kiechl, and G. Wick. 2000. Serum soluble heat shock protein 60 is elevated in subjects with atherosclerosis in a general population. Circulation 102:14-20.
28. Zanin-Zhorov, A., G. Tal, S. Shivtiel, M. Cohen, T. Lapidot, G. Nussbaum, R. Margalit, I. R. Cohen, and O. Lider. 2005. Heat shock protein 60 activates cytokine-associated negative regulator suppressor of cytokine signaling 3 in T cells: effects on signaling, chemotaxis, and inflammation. J. Immunol. 175:276-285.
29. Zugel, U., and S. H. Kaufmann. 1999. Immune response against heat shock proteins in infectious diseases. Immunobiology 201:22-35.